Alector Therapeutics said Monday that its Phase 2 trial for an experimental Alzheimer’s antibody failed, dealing a blow to what had been one of the
Four years on, the Cassava Sciences story ended Monday exactly as many knew it would — with the company’s experimental drug for Alzheimer’s disease, simufilam,
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! After reading Katie Palmer’s great
Minnesota hospitals participating in a controversial U.S. drug discount program reaped at least $630 million in revenue last year, and the largest institutions were the
Vancouver, British Columbia–(Newsfile Corp. – November 25, 2024) – Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) (the “Company“) announces release of
VANCOUVER, British Columbia, Nov. 25, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the
What You Should Know: – Hospitals across the country are facing an ever-increasing onslaught of claims denials from insurance companies, with denials up 20.2% in 2023,
Dive Brief: Boston Scientific said Monday it has agreed to acquire Intera Oncology, which makes treatments for liver tumors primarily caused by metastatic colorectal cancer.
Dive Brief: Medtronic and Tempus have begun a study to assess the use of artificial intelligence to identify patients with symptomatic severe aortic stenosis, the companies
Acreage Provides Update on Corporate Transactions NEW YORK, NY / ACCESSWIRE / November 25, 2024 / Acreage Holdings, Inc. (“Acreage” or the “Company”) (CSE:ACRG.A.U, ACRG.B.U)(OTCQX:ACRHF,